Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-16 · accession 0001415889-25-008620 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-19 | 2025-01-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $16.00 | +1,118 | 22.9K | +5% | +$17.9K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $22.61 | -292 | 23.6K | -1% | -$6,602 |
| D | 2025-03-19 | 2025-03-16 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +994 | 23.8K | +4% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -994 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-01-15 | A | A | 1,118 | $16.00 | 22,854 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-03-16 | F | D | 292 | $22.61 | 23,556 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-03-16 | M | A | 994 | — | 23,848 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 4 | Derivative | Restricted Share Unit | 2025-03-16 | M | D | 994 | $0.00 | 0 | D | — · — to — | 994 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021. |